Medicinos erdvė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 275,230 | 332,199 | 330,108 | 509,389 | 639,851 | 657,421 | 813,798 | 741,488 |
| Profit before tax | 1,056 | 28,744 | 52,908 | 115,576 | 67,100 | 25,137 | 5,242 | 14,597 |
| Net profit | 1,002 | 24,123 | 44,767 | 97,945 | 56,822 | 29,700 | 3,722 | 12,387 |
| Equity | 9,808 | 33,931 | 78,698 | 176,643 | 233,465 | 254,039 | 257,761 | 270,148 |
| Liabilities | 105,573 | 142,793 | 123,133 | 148,272 | 92,468 | 249,650 | 251,842 | 240,675 |
| Non-current assets | 10,682 | 53,052 | 67,745 | 110,050 | 102,924 | 308,443 | 229,368 | 240,912 |
| Current assets | 104,699 | 123,672 | 134,086 | 214,865 | 223,009 | 198,835 | 283,024 | 271,900 |
| Total assets | 115,381 | 176,724 | 201,831 | 324,915 | 325,933 | 507,278 | 512,392 | 512,812 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 107,166 | 142,171 | 154,975 |
| Social insurance contributions | - | - | - | - | - | 20,654 | 27,755 | 32,589 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +39.9% | +20.7% | -0.6% | +54.3% | +25.6% | +2.7% | +23.8% | -8.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.9% | 13.7% | 22.2% | 30.1% | 17.4% | 5.9% | 0.7% | 2.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 10.2% | 71.1% | 56.9% | 55.4% | 24.3% | 11.7% | 1.4% | 4.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.4% | 7.3% | 13.6% | 19.2% | 8.9% | 4.5% | 0.5% | 1.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.4% | 8.7% | 16.0% | 22.7% | 10.5% | 3.8% | 0.6% | 2.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 10.8 | 4.2 | 1.6 | 0.8 | 0.4 | 1.0 | 1.0 | 0.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 55,046 | 78,164 | 63,891 | 89,892 | 121,876 | 133,712 | 128,495 | 105,927 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medicinos erdvė - Social security debts
The company had no debts to Sodra
Medicinos erdvė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-04 | 2025-04-04 | 1656.58 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medicinos erdve, UAB (code 302485249) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated EUR 741.5K in revenue, down 8.9% from 2024, while revenue remained above the 2023 level by 12.8% over two years. Profitability improved from the weak 2024 result: net profit rose to EUR 12.4K in 2025 from EUR 3.7K in 2024, though it was still below the EUR 29.7K achieved in 2023. The 2025 net profit margin was 1.7%, compared with 0.5% in 2024 and 4.5% in 2023. At the end of 2025, total assets were EUR 512.8K, equity EUR 270.1K and liabilities EUR 240.7K, indicating a balanced capital structure with an equity ratio of 52.7% and debt-to-equity of 0.89. Return on equity was 4.6% and return on assets 2.4%. Asset turnover was 1.45x. Revenue per employee was EUR 105.9K and profit per employee EUR 1.8K.